First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013

T W Boo; N O’Connell; L Power; M O’Connor; J King; E McGrath; R Hill; K L Hopkins; N Woodford

doi:10.2807/1560-7917.ES2013.18.31.20548

Rapid communications Open Access

Like 0

Download

First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013
T W Boo^1,2 , N O’Connell³ , L Power³ , M O’Connor⁴ , J King¹ , E McGrath¹ , R Hill⁵ , K L Hopkins⁵ , N Woodford⁵
View Affiliations Hide Affiliations

Affiliations: ¹ Department of Medical Microbiology, Galway University Hospitals, HSE West, Ireland ² Discipline of Bacteriology, School of Medicine, National University of Ireland Galway, Ireland ³ Department of Clinical Microbiology, Mid-western Regional Hospital, Limerick, HSE West, Ireland ⁴ Department of Geriatric Medicine, Mid-western Regional Hospital, Limerick, HSE West, Ireland ⁵ Antimicrobial Resistance and Healthcare Associated Infections Reference Unit, PHE Colindale, London, United Kingdom

Correspondence:
T Boo
teck.boo hse.ie
View Citation Hide Citation

Citation style for this article: Boo T W, O’Connell N, Power L, O’Connor M, King J, McGrath E, Hill R, Hopkins K L, Woodford N. First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013. Euro Surveill. 2013;18(31):pii=20548. https://doi.org/10.2807/1560-7917.ES2013.18.31.20548 Received: 02 Jul 2013

Abstract

We report the first case in Ireland of an IMI-1 carbapenemase-producing Enterobacter asburiae, which was resistant to both colistin and fosfomycin. The circumstances under which this isolate was acquired were unclear. Several reports of IMI-producing Enterobacter spp. have emerged in recent years, and colistin resistance in Enterobacteriaceae is also increasingly reported. Laboratories should be aware of the unusual antibiograms of IMI-producing isolates.

This work is licensed under a Creative Commons Attribution 4.0 International License.

Article metrics loading...

/content/10.2807/1560-7917.ES2013.18.31.20548

2013-08-01

2021-05-12

Click here for cited by

http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES2013.18.31.20548

From This Site

/content/10.2807/1560-7917.ES2013.18.31.20548

dcterms_title,dcterms_subject,pub_keyword

-contentType:Journal -contentType:Contributor -contentType:Concept -contentType:Institution

10

5
PubMed
Google Scholar

Full text loading...

/deliver/fulltext/eurosurveillance/18/31/art20548-en.htm?itemId=/content/10.2807/1560-7917.ES2013.18.31.20548&mimeType=html&fmt=ahah

Submit comment

Comment moderation successfully completed

Submit your article here

Submit an Article

Tools

News/announcements

ESCAIDE 2021 call for abstracts is open from 19 April to 19 May. The conference welcomes abstracts in all areas related to infectious disease prevention and control, including epidemiology, public health microbiology, surveillance, and the application of tools and methods to support infectious disease outbreaks or interventions. There will also be a late breaker call in September for issues arising after the close of the main abstract call. More information and guidelines can be found here.

First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013

Abstract

Click here for cited by

From This Site

PubMed

Google Scholar